Expert Guidance to Optimize Therapy Decisions for Head and Neck Squamous Cell Carcinoma

This comprehensive program gathers expert insights into the management of patients with locoregionally advanced and metastatic HNSCC featuring an Interactive Decision Support Tool that lets clinicians compare their treatment choices for specific patient scenarios with those of 5 experts. Also included is a complementary expert-authored module with downloadable slideset with a focus on the most clinically important developments in leveraging checkpoint inhibitors for HNSCC.

Share

Program Content

Activities

HNSCC Treatment
Incorporating Checkpoint Inhibitor Therapy Into the Management of Head and Neck Squamous Cell Carcinoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 03, 2019

Expires: September 01, 2020

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Merck Oncology